- Does Abdominal Obesity Accelerate the Effect of Hypertriglyceridemia on Impaired Fasting Glucose?
-
Lee S, Chun K, Lee S, Kim D
- KMID: 1074987
- Yonsei Med J.
- 2010 May;51(3):360-366.
- doi: 10.3349/ymj.2010.51.3.360
PURPOSE: This study sought to determine whether abdominal obesity is a risk factor for impaired fasting glucose (IFG) and hypertriglyceridemia and to verify whether moderate effect of abdominal obesity on... -
- CITED
-
- Close
- SHARE
-
- Close
- A Telephone-Delivered Intervention to Improve Glycemic Control in Type 2 Diabetic Patients
-
Oh JA, Kim HS, Yoon KH, Choi ES
- KMID: 1719062
- Yonsei Med J.
- 2003 Feb;44(1):1-8.
- doi: 10.3349/ymj.2003.44.1.1
This study was performed to investigate the effect of a telephone-delivered intervention on glycemic control and body mass index in Korean type 2 diabetic patients. 38 patients were randomly selected,... -
- CITED
-
- Close
- SHARE
-
- Close
- Postpartum Glucose Testing Rates Following Gestational Diabetes Mellitus and Factors Affecting Testing Non-compliance from Four Tertiary Centers in Korea
-
Cho GJ, An JJ, Choi SJ, Oh SY, Kwon HS, Hong SC, Kwon JY
- KMID: 2359970
- J Korean Med Sci.
- 2015 Dec;30(12):1841-1846.
- doi: 10.3346/jkms.2015.30.12.1841
The purpose of this study was to investigate postpartum glucose testing rates in patients with gestational diabetes mellitus (GDM) and to determine factors affecting testing non-compliance in the Korean population.... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular Mechanism of Insulin Resistance in Obesity and Type 2 Diabetes
-
Choi K, Kim YB
- KMID: 1785667
- Korean J Intern Med.
- 2010 Jun;25(2):119-129.
- doi: 10.3904/kjim.2010.25.2.119
Insulin resistance is a major risk factor for developing type 2 diabetes caused by the inability of insulin-target tissues to respond properly to insulin, and contributes to the morbidity of... -
- CITED
-
- Close
- SHARE
-
- Close
- Estimating Average Glucose Levels from Glycated Albumin in Patients with End-Stage Renal Disease
-
Kim JK, Park JT, Oh HJ, Yoo DE, Kim SJ, Han SH, Kang SW, Choi KH, Yoo TH
- KMID: 1776994
- Yonsei Med J.
- 2012 May;53(3):578-586.
- doi: 10.3349/ymj.2012.53.3.578
PURPOSE: In patients with diabetic end stage renal disease (ESRD), glycated albumin (GA) reflects recent glycemic control more accurately than glycated hemoglobin (HbA1c). We evaluated the relationship between GA and... -
- CITED
-
- Close
- SHARE
-
- Close
- Fasting Plasma Glucose Cutoff Value for the Prediction of Future Diabetes Development: A Study of Middle-Aged Koreans in a Health Promotion Center
-
Kim DJ, Cho NH, Noh JH, Kim HJ, Choi YH, Jung JH, Min YK, Lee MS, Lee MK, Kim KW
- KMID: 1712733
- J Korean Med Sci.
- 2005 Aug;20(4):562-565.
- doi: 10.3346/jkms.2005.20.4.562
We determined optimal fasting plasma glucose (FPG) cutoff values predictive of future diabetes development in a group of middle-aged Koreans who visited a health promotion center. The medical records of... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
-
Kim G, Lee YH, Kang ES, Cha BS, Lee HC, Lee BW
- KMID: 2427157
- Yonsei Med J.
- 2016 Nov;57(6):1395-1403.
- doi: 10.3349/ymj.2016.57.6.1395
PURPOSE: The objective of this study was to investigate clinical and laboratory parameters that could predict which patients could maintain adequate glycemic control after switching from initial insulin therapy to... -
- CITED
-
- Close
- SHARE
-
- Close
- Soy Protein Supplementation Reduces Clinical Indices in Type 2 Diabetes and Metabolic Syndrome
-
Zhang XM, Zhang YB, Chi MH
- KMID: 2374089
- Yonsei Med J.
- 2016 May;57(3):681-689.
- doi: 10.3349/ymj.2016.57.3.681
PURPOSE: Clinical trials have studied the use of soy protein for treating type 2 diabetes (T2D) and metabolic syndrome (MS). The purpose of this study was to outline evidence on... -
- CITED
-
- Close
- SHARE
-
- Close
